Investing.com - AstraZeneca ADR reported on Thursday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
AstraZeneca ADR announced earnings per share of $0.96 on revenue of $6.28B. Analysts polled by Investing.com anticipated EPS of $0.45 on revenue of $6.23B.
AstraZeneca ADR shares are down 38% from the beginning of the year and are trading at $56.64 , down-from-52-week-high.They are under-performing the CAC 40 which is down 18.02% from the start of the year.
AstraZeneca ADR follows other major Healthcare sector earnings this month
AstraZeneca ADR's report follows an earnings beat by J&J on Thursday, July 16, 2020, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Roche Holding ADR had beat expectations on Thursday, July 23, 2020 with second quarter EPS of $1.45 on revenue of $15.27B, compared to forecast for EPS of $1.42 on revenue of $15.69B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar